The identification of exosomal lncRNA LIFR-AS1 as a potential biomarker for evaluating osteosarcoma metastasis offers new possibilities for therapeutic approaches in the treatment of this aggressive tumor. This evidence concerns the gene LIFR and osteosarcoma.